Biofrontera (NASDAQ:BFRI) stockholders approved all three proposals presented at the company’s annual meeting, including the election of two Class II directors and an expansion of the company’s 2021 Omnibus Incentive Plan, according to preliminary voting results announced during the meeting. Chief Executive Officer and Chairman Hermann Lübbert presided over the virtual meeting, which was recorded […]